Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid gel for genitourinary syndrome of menopause
ChiCTR2300077525Phase 2Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Sep 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium hyaluronate in vaginal atrophy (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Improvement of symptoms. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
sodium hyaluronate
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on ChiCTR2300077525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077525.